BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24370333)

  • 1. Alterations of endocannabinoids in cerebrospinal fluid of dogs with epileptic seizure disorder.
    Gesell FK; Zoerner AA; Brauer C; Engeli S; Tsikas D; Tipold A
    BMC Vet Res; 2013 Dec; 9():262. PubMed ID: 24370333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
    Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M
    Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction.
    Zoerner AA; Batkai S; Suchy MT; Gutzki FM; Engeli S; Jordan J; Tsikas D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():161-71. PubMed ID: 21752730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms.
    Morgan CJ; Page E; Schaefer C; Chatten K; Manocha A; Gulati S; Curran HV; Brandner B; Leweke FM
    Br J Psychiatry; 2013 May; 202(5):381-2. PubMed ID: 23580381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative profiling of endocannabinoids and related
    Kantae V; Ogino S; Noga M; Harms AC; van Dongen RM; Onderwater GL; van den Maagdenberg AM; Terwindt GM; van der Stelt M; Ferrari MD; Hankemeier T
    J Lipid Res; 2017 Mar; 58(3):615-624. PubMed ID: 27999147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.
    Nicholson J; Azim S; Rebecchi MJ; Galbavy W; Feng T; Reinsel R; Rizwan S; Fowler CJ; Benveniste H; Kaczocha M
    PLoS One; 2015; 10(4):e0123132. PubMed ID: 25835291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
    Sarchielli P; Pini LA; Coppola F; Rossi C; Baldi A; Mancini ML; Calabresi P
    Neuropsychopharmacology; 2007 Jun; 32(6):1384-90. PubMed ID: 17119542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid system in canine Steroid-Responsive Meningitis-Arteritis and Intraspinal Spirocercosis.
    Freundt-Revilla J; Heinrich F; Zoerner A; Gesell F; Beyerbach M; Shamir M; Oevermann A; Baumgärtner W; Tipold A
    PLoS One; 2018; 13(2):e0187197. PubMed ID: 29408878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-Specific Derangement of Circulating Endocannabinoids and
    Forte D; Fanelli F; Mezzullo M; Barone M; Corradi G; Auteri G; Bartoletti D; Martello M; Ottaviani E; Terragna C; Curti A; Pagotto U; Palandri F; Cavo M; Catani L
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.
    Di Filippo M; Pini LA; Pelliccioli GP; Calabresi P; Sarchielli P
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1224-9. PubMed ID: 18535023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study.
    Valastro C; Campanile D; Marinaro M; Franchini D; Piscitelli F; Verde R; Di Marzo V; Di Bello A
    BMC Vet Res; 2017 Nov; 13(1):309. PubMed ID: 29110674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of anandamide in cerebrospinal fluid samples by disposable pipette extraction and ultra-high performance liquid chromatography tandem mass spectrometry.
    Oliveira IGC; Marchioni C; Queiroz MEC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Nov; 1130-1131():121809. PubMed ID: 31669634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy.
    Colangeli R; Morena M; Pittman QJ; Hill MN; Teskey GC
    J Neurosci; 2020 Jul; 40(31):6068-6081. PubMed ID: 32601243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid lactate concentrations in dogs with seizure disorders.
    Mariani CL; Nye CJ; Ruterbories L; Tokarz DA; Green L; Lau J; Zidan N; Early PJ; Muñana KR; Olby NJ; Lee CS; Guevar J
    J Vet Intern Med; 2020 Nov; 34(6):2562-2570. PubMed ID: 33135819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatography-mass spectrometry-based metabolic profiling of cerebrospinal fluid from epileptic dogs.
    Hasegawa T; Sumita M; Horitani Y; Tamai R; Tanaka K; Komori M; Takenaka S
    J Vet Med Sci; 2014 Apr; 76(4):517-22. PubMed ID: 24334864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma endocannabinoids and cannabimimetic fatty acid derivatives are altered in gastroparesis: A sex- and subtype-dependent observation.
    Bashashati M; Leishman E; Bradshaw H; Sigaroodi S; Tatro E; Bright T; McCallum R; Sarosiek I
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13961. PubMed ID: 32779297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-α and interleukin-6 concentrations in cerebrospinal fluid of dogs after seizures.
    Merbl Y; Sommer A; Chai O; Aroch I; Zimmerman G; Friedman A; Soreq H; Shamir MH
    J Vet Intern Med; 2014; 28(6):1775-81. PubMed ID: 25308784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes.
    Thompson Z; Argueta D; Garland T; DiPatrizio N
    Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG.
    Oláh M; Milloh H; Wenger T
    Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S36-40. PubMed ID: 18308464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
    Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
    Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.